Susquehanna International Group, LLP Global Blood Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.05 Million - $2.21 Million	32,468 Added 215.42%	47,540 $3.24 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $889,390 - $1.49 Million	-39,883 Reduced 72.57%	15,072 $482,000
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.88 Million - $2.6 Million	-73,037 Reduced 57.06%	54,955 $1.9 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $1.19 Million - $1.92 Million	-47,693 Reduced 27.15%	127,992 $3.75 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $236,479 - $346,552	9,281 Added 5.58%	175,685 $4.48 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $43.42 $1.38 Million - $1.84 Million	42,376 Added 34.17%	166,404 $5.83 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $1.21 Million - $1.58 Million	31,059 Added 33.41%	124,028 $5.05 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $3.91 Million - $6.62 Million	-103,851 Reduced 52.76%	92,969 $4.03 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $4.64 Million - $6.55 Million	87,939 Added 80.77%	196,820 $10.9 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $2.47 Million - $4.15 Million	-50,767 Reduced 31.8%	108,881 $6.87 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $5.32 Million - $11.1 Million	127,411 Added 395.23%	159,648 $8.16 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $8.65 Million - $15.5 Million	-189,207 Reduced 85.44%	32,237 $2.56 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $31,699 - $40,479	-699 Reduced 0.31%	221,444 $10.7 Million
Q2 2019 Aug 16, 2019	BUY	$52.6 - $63.29 $1.25 Million - $1.51 Million	23,821 Added 12.01%	222,143 $11.7 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $533,679 - $642,140	-10,146 Reduced 4.87%	198,322 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $5.51 Million - $8.15 Million	174,544 Added 514.51%	208,468 $8.56 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $7.75 Million - $10.4 Million	-203,885 Reduced 85.73%	33,924 $1.29 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $4.7 Million - $6.09 Million	121,385 Added 104.26%	237,809 $10.7 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $3.46 Million - $5.32 Million	116,424	116,424 $4.58 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account